However, recent studies found that Tie2 expression and activity are not limited to the vasculatures alone, but also expressed by cancer cells and other cell types within the tumour microenvironment, including tumour-associated macrophages in glioblastomas, ovarian, thyroid, gastric and breast cancers [29,46]. Here, TEK is linked to breast cancer.